TipRanks
Go Ultimate55% OFF

Elixinol Wellness (EXL) Share Price & Analysis

EXL Stock Chart & Stats

A$0.02A$0.00(16.67%)
At close: 9:59 AM GMT+10
AU$0.01AU$0.0125AU$0.01523 Feb6 Mar15 May18 May
Day’s Range
AUD 0.01 - AUD 0.02
52-Week Range
AUD 0.01 - AUD 0.02
Previous Close
AUD 0.02
Volume
100.00K
Average Volume (3M)
5.67M
Market Cap
AUD 2.72M
Enterprise Value
AUD 5.52M
Total Cash (Recent Filing)
AUD 996.00K
Total Debt (Recent Filing)
AUD 4.03M
Price to Earnings (P/E)
―
Beta
-1.17
Next Earnings
Feb 19, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

Revenue has recovered materially from the 2022–2023 base, indicating that the company retains demand for its branded hemp and CBD wellness products. Although 2025 growth turned negative, the higher revenue platform may support future operating improvement if the business can restore margins and control costs.

Historically Moderate Leverage

Historically moderate debt-to-equity suggests the company had some balance-sheet capacity relative to its equity base before the 2025 deterioration. This provides a stronger starting position than a highly leveraged structure, although preserving that flexibility depends on reducing losses and avoiding further debt increases.

Improving Cash Burn

The direction of cash generation has improved from the much heavier burn recorded in 2020–2022, while 2025 free cash flow was better than in 2024. This suggests some progress in financial control, creating a potential foundation for stronger funding capacity if operations eventually reach positive cash generation.

Bears Say

Persistent Losses

Recurring negative EBIT and net income show that the business has not yet demonstrated durable profitability across the reported period. Continued losses reduce retained capital, limit internally funded investment, and make the company more dependent on operational improvement or external financing to sustain its strategy.

Severe Margin Pressure

The sharp fall in gross profit despite the recovery in revenue indicates substantial pressure on product economics and margin sustainability. If this deterioration persists, higher sales may not translate into improved earnings, weakening the scalability of the branded wellness and CBD business model.

Negative Cash Generation

Consistently negative operating and free cash flow means the company has not shown an ability to fund operations internally. Ongoing cash burn increases reliance on financing while losses persist, reducing strategic flexibility and making balance-sheet resilience more important over the next several quarters.

Elixinol Wellness News

EXL FAQ

What was Elixinol Wellness’s price range in the past 12 months?
Elixinol Wellness lowest share price was AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Elixinol Wellness’s market cap?
Elixinol Wellness’s market cap is AU$2.72M.
When is Elixinol Wellness’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Elixinol Wellness’s earnings last quarter?
Elixinol Wellness released its earnings results on Aug 31, 2026. The company reported -AU$0.003 earnings per share for the quarter.
Is Elixinol Wellness overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Elixinol Wellness pay dividends?
Elixinol Wellness does not currently pay dividends.
What is Elixinol Wellness’s EPS estimate?
Elixinol Wellness’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elixinol Wellness have?
Elixinol Wellness has 454,112,180 shares outstanding.
What happened to Elixinol Wellness’s price movement after its last earnings report?
Elixinol Wellness reported an EPS of -AU$0.003 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Elixinol Wellness?
Currently, no hedge funds are holding shares in AU:EXL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology